IL89480A - Oxindole 1,7-anilate-3-carboxamides and pharmaceutical preparations containing them - Google Patents

Oxindole 1,7-anilate-3-carboxamides and pharmaceutical preparations containing them

Info

Publication number
IL89480A
IL89480A IL8948089A IL8948089A IL89480A IL 89480 A IL89480 A IL 89480A IL 8948089 A IL8948089 A IL 8948089A IL 8948089 A IL8948089 A IL 8948089A IL 89480 A IL89480 A IL 89480A
Authority
IL
Israel
Prior art keywords
compound
thiazolyl
carboxamide
phenyl
formula
Prior art date
Application number
IL8948089A
Other languages
English (en)
Hebrew (he)
Other versions
IL89480A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL89480A0 publication Critical patent/IL89480A0/xx
Publication of IL89480A publication Critical patent/IL89480A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL8948089A 1988-03-11 1989-03-03 Oxindole 1,7-anilate-3-carboxamides and pharmaceutical preparations containing them IL89480A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/000781 WO1989008654A1 (en) 1988-03-11 1988-03-11 Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds

Publications (2)

Publication Number Publication Date
IL89480A0 IL89480A0 (en) 1989-09-10
IL89480A true IL89480A (en) 1994-04-12

Family

ID=22208596

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8948089A IL89480A (en) 1988-03-11 1989-03-03 Oxindole 1,7-anilate-3-carboxamides and pharmaceutical preparations containing them

Country Status (15)

Country Link
EP (1) EP0332364A3 (da)
JP (1) JPH0676408B2 (da)
KR (1) KR910002565B1 (da)
AU (1) AU605410B2 (da)
CA (1) CA1335592C (da)
DK (1) DK169723B1 (da)
FI (1) FI96315C (da)
HU (1) HU201757B (da)
IL (1) IL89480A (da)
MY (1) MY104955A (da)
NO (1) NO170418C (da)
NZ (1) NZ228299A (da)
PT (1) PT89954B (da)
WO (1) WO1989008654A1 (da)
ZA (1) ZA891800B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
JPH06279444A (ja) * 1993-03-31 1994-10-04 Tokyo Tanabe Co Ltd インドリジン誘導体
JP2002504549A (ja) * 1998-02-26 2002-02-12 ニューロゲン コーポレイション ベンジルピペラジニル−およびベンジルピペリジニルエタノン誘導体、その調製、およびドーパミンｄ４受容体アンタゴニストとしてのその使用
US6084098A (en) 1999-02-26 2000-07-04 Neurogen Corporation Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
CN101014345A (zh) * 2004-09-09 2007-08-08 默克公司 三环酰苯胺螺环内酰胺cgrp受体拮抗剂
AU2005285083B2 (en) * 2004-09-13 2011-03-10 Merck Sharp & Dohme Corp. Tricyclic anilide spirohydantoin CGRP receptor antagonists
US7741317B2 (en) * 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
CN108853102B (zh) * 2017-05-15 2021-04-09 北京大学 作用于Dectin-1的稠合吖啶衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394373A (en) * 1972-05-17 1975-05-14 Pfizer Ltd Control of plant diseases
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
FR2567126B1 (fr) * 1984-07-06 1986-12-12 Synthelabo Derives de pyrrolo(1,2,3-de) benzoxazine et benzothiazine, leur preparation et leur application en therapeutique
JPS6317885A (ja) * 1986-07-11 1988-01-25 Kyorin Pharmaceut Co Ltd スピロピロリジン−２，５−ジオン誘導体の製造方法

Also Published As

Publication number Publication date
JPH01275580A (ja) 1989-11-06
NO894350L (no) 1989-11-01
HU201757B (en) 1990-12-28
AU3120489A (en) 1989-09-14
EP0332364A3 (en) 1991-04-03
WO1989008654A1 (en) 1989-09-21
MY104955A (en) 1994-07-30
PT89954B (pt) 1994-05-31
KR890014545A (ko) 1989-10-24
AU605410B2 (en) 1991-01-10
NZ228299A (en) 1990-09-26
FI895333A0 (fi) 1989-11-09
FI96315B (fi) 1996-02-29
PT89954A (pt) 1989-11-10
DK116689A (da) 1989-09-12
CA1335592C (en) 1995-05-16
NO170418B (no) 1992-07-06
FI96315C (fi) 1996-06-10
EP0332364A2 (en) 1989-09-13
JPH0676408B2 (ja) 1994-09-28
ZA891800B (en) 1990-10-31
NO170418C (no) 1992-10-14
NO894350D0 (no) 1989-11-01
DK169723B1 (da) 1995-01-23
DK116689D0 (da) 1989-03-10
IL89480A0 (en) 1989-09-10
KR910002565B1 (ko) 1991-04-26
HU885829D0 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
US5624931A (en) Pyrazole derivatives
EP0547708B1 (en) Saccharin derivative proteolytic enzyme inhibitors
CA1103246A (en) Thiazine derivatives
US5468898A (en) Substituted naphthylene compounds exhibiting selective leukotriene B4 antagonist activity
KR890001549B1 (ko) 치환된 피리미딘 및 이의 제조방법
JPS62201882A (ja) イソフラボン誘導体
WO1992012154A1 (en) Imidazotriazine derivatives
CA2122886A1 (en) Saccharin derivative proteolytic enzyme inhibitors
AU716008B2 (en) Bicyclic benzazepine derivatives as vasopressin antagonists
US5739130A (en) Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
AU650041B2 (en) Tricyclic benzodiazepine derivates their preparation and pharmaceutical compositions containing them
US5438052A (en) Cephalosporin derivatives
IL89480A (en) Oxindole 1,7-anilate-3-carboxamides and pharmaceutical preparations containing them
US4076709A (en) Thienothiazines
EP0173520B1 (en) Tricyclic oxindole antiinflammatory agents
CA2241690A1 (en) Pyrido(2,3-b)pyrazine derivatives
Mylari et al. 1, 2-Dihydro-1-oxopyrrolo [3, 2, 1-kl] phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with anti-inflammatory activity
US5624929A (en) Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
JPH07242666A (ja) 複素環化合物
US5403839A (en) Pyrrolophenothiazine carboxamides
US5952335A (en) Fused polycyclic heterocycle derivatives
EP0306300B1 (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
EP0294994B1 (en) 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides
JPH01216997A (ja) 新規セフェム化合物ならびにその製造法
HU211286A9 (hu) Proteolitikus enzimeket gátló szacharinszármazékok Az átmeneti oltalom az 1-5. és 8. igénypontokra vonatkozik.

Legal Events

Date Code Title Description
RH Patent void